4 Perspectives on Sustainability in Clinical Research
As studies become more complex, stakeholders must be aware of the resources they are utilizing and their impact on the environment.
Sustainability in clinical research is key. As complexity and productivity in the industry continue to rise, so does the need for additional resources. According to a recent IQVIA Institute for Human Data Science report, clinical development productivity rose to its highest level since 2018.
Stakeholders must be keen on how they utilize clinical resources, even with positive trends in productivity and development. With strategic management, industry can ensure the long-term effectiveness of clinical trials and their ability to bring therapies to patients faster.
In this slideshow, Julia Sundari, senior director of clinical design and analytics, IQVIA; Michael Cohen, MSc, MBA, senior director, lead, environmental sustainability, PPD clinical research business of Thermo Fisher Scientific; Robyn Owens, manager, recruitment and engagement, PPD clinical research business of Thermo Fisher Scientific; Bill Sterling, senior director of environmental, health and safety, IQVIA Laboratories; and Bryan Spielman, chief growth officer, Advarra each share a critical component to ensuring the long-term effectiveness of clinical research.
Image Credit: © Dee karen - stock.adobe.com
What Can ClinOps Learn from Pre-Clinical?
August 10th 2021Dr. Hanne Bak, Senior Vice President of Preclinical Manufacturing and Process Development at Regeneron speaks about her role at the company as well as their work with monoclonal antibodies, the regulatory side of manufacturing, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
